Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to $506000.0.

  • Select Medical Holdings' Asset Writedowns and Impairment fell 9466.19% to $506000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.2 million, marking a year-over-year decrease of 651.45%. This contributed to the annual value of $19.0 million for FY2024, which is 174834.95% up from last year.
  • According to the latest figures from Q3 2025, Select Medical Holdings' Asset Writedowns and Impairment is $506000.0, which was down 9466.19% from -$728000.0 recorded in Q2 2025.
  • In the past 5 years, Select Medical Holdings' Asset Writedowns and Impairment registered a high of $9.5 million during Q3 2024, and its lowest value of -$728000.0 during Q2 2025.
  • In the last 5 years, Select Medical Holdings' Asset Writedowns and Impairment had a median value of $215000.0 in 2022 and averaged $1.2 million.
  • As far as peak fluctuations go, Select Medical Holdings' Asset Writedowns and Impairment crashed by 28000.0% in 2022, and later surged by 1150704.23% in 2024.
  • Quarter analysis of 5 years shows Select Medical Holdings' Asset Writedowns and Impairment stood at $64000.0 in 2021, then skyrocketed by 235.94% to $215000.0 in 2022, then tumbled by 133.02% to -$71000.0 in 2023, then surged by 11507.04% to $8.1 million in 2024, then tumbled by 93.75% to $506000.0 in 2025.
  • Its Asset Writedowns and Impairment was $506000.0 in Q3 2025, compared to -$728000.0 in Q2 2025 and $2.3 million in Q1 2025.